Optimization of the preparation of chitosan nanoparticles loaded with bifendate using the Box-Behnken design

被引:0
作者
Yang, Lifeng [1 ]
Zheng, Pinjin [1 ]
Chen, Zexin [1 ]
机构
[1] Guangdong Ocean Univ, 1 Hailu Rd, Zhanjiang, Guangdong, Peoples R China
关键词
Bifendate; Chitosan nanoparticles; Box-Behnken design;
D O I
10.1016/j.rechem.2025.102085
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The aim of this research is to explore new techniques for preparing a cross-linked three-dimensional network nanogel structure (CS-NPS) loaded with bifendate (DDB). The ionic cross-linking method was used to prepare CSNPS from tripolyphosphate (TPP) and chitosan (CS), and DDB was then encapsulated in the nanogel structure to obtain DDB-CS-NPS. The preparation conditions were optimized through single-variable experiments and the Box-Behnken response surface method to obtain DDB-CS-NPS with good system stability, moderate particle size, and good encapsulation efficiency. It was found that when the TPP concentration was 1.5 mg/ml, the feed ratio was 3.8:1, and the ultrasound treatment time was 10 min and 53 s, the encapsulation efficiency predicted by the Box-Behnken response surface method could reach 89.38 %. A verification test showed that the actual average encapsulation efficiency of the DDB-CS-NPS reached 88.64 %, and the deviation between the predicted and the actual values was -0.8220 %. The average particle size of the samples was 644.8 nm, the polydispersity index was 0.301, and the zeta potential was 6.68 +/- 1.29 mV. The results indicate that the proposed preparation process is feasible, the response surface test model can accurately predict the preparation condition area of DDB-CS-NPS, the deviation between the predicted encapsulation efficiency and the actual value is small, and the encapsulation efficiency meets the expected requirements. The DDB-CS-NPS obtained has a moderate particle size, a uniform distribution, and a relatively low potential. However, it may be prone to aggregation or coagulation, and so should be stored in a refrigerated condition.
引用
收藏
页数:9
相关论文
共 28 条
[1]  
Chen H., 2023, J. China Pharmaceut., V31, P128
[2]  
Chen S., 2017, Synthesis of Redox-Responsive Amphiphilic Chitosan Derivatives and their Characteristics Nanocarriers
[3]   Chitosan Nanoparticles Production: Optimization of Physical Parameters, Biochemical Characterization, and Stability upon Storage [J].
Costa, Eduardo M. ;
Silva, Sara ;
Pintado, Manuela .
APPLIED SCIENCES-BASEL, 2023, 13 (03)
[4]  
Duan H., 2021, CHINA PHARMACY, V32, P1692, DOI DOI 10.6039/j.issn.1001-0408.2021.14.05
[5]  
Huang X., 2022, J. Chem. Agent, V44, P239
[6]   Recent progressions in biomedical and pharmaceutical applications of chitosan nanoparticles: A comprehensive review (Publication with Expression of Concern. See vol. 283, 2024) [J].
Khalaf, Eman M. ;
Abood, Noor Adil ;
Atta, Raghad Z. ;
Ramirez-Coronel, Andres Alexis ;
Alazragi, Reem ;
Parra, Rosario Mireya Romero ;
Abed, Osama H. ;
Abosaooda, Munther ;
Jalil, Abduladheem Turki ;
Mustafa, Yasser Fakri ;
Narmani, Asghar ;
Farhood, Bagher .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2023, 231
[7]   BIFENDATE INDIRECTLY INHIBITS ALANINE TRANSAMINASE RELEASE WITHOUT DIRECT INTERACTION IN VITRO AND IN VIVO [J].
Li, Hu ;
Liu, Nan-Nan ;
Li, Jian-Rui ;
Wang, Mei-Xi ;
Tan, Jia-Li ;
Zou, Li-Li ;
Dong, Biao ;
Peng, Zong-Gen ;
Jiang, Jian-Dong .
ACTA POLONIAE PHARMACEUTICA, 2020, 77 (04) :629-635
[8]  
Lin B., 2008, J. Chem. Intermediate, V07, P20
[9]  
Liu C., 2022, J. Chin. Res., V34, P21
[10]  
Liu G., 1983, J. Acta. Pharmaceutica. Sinica, V9, P714